TMPRSS2-ERG is a fusion transcript that emerges as prostate cancer cells specific biomarker; when overexpressed, it plays a pivotal role in prostate cancer transformation, EMT and invasion [117–120]. This evidence concerns the gene ERG and prostate cancer.